Physician profile
Morhaf Ibrahim
NPI 1437485786
$14,678.37
in general payments reported to CMS, 2019-2025
41 companies · $1,462 in 2025
The $1,462 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,624 · 2020: $522 · 2021: $1,284 · 2022: $1,569 · 2023: $4,165 · 2024: $2,052 · 2025: $1,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,830 · Travel and Lodging: $2,849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,829.85 |
| Travel and Lodging | $2,848.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,234.59 | 2019-2025 | Aveir, Amplatzer Amulet, Mitraclip |
| Biosense Webster, INC. | $3,315.75 | 2019-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Boston Scientific Corporation | $1,008.11 | 2019-2025 | Watchman Flx, Watchman, Lux-Dx Insertable Cardiac Monitor |
| Biotronik INC. | $909.46 | 2020-2025 | Biomonitor |
| Novartis Pharmaceuticals Corporation | $906.66 | 2019-2025 | |
| Pfizer INC. | $574.13 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $489.76 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $337.13 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $306.08 | 2021-2025 | Farxiga |
| Philips North America LLC | $277.68 | 2022-2025 | (Ck4) Mcot, (Ck7) Extended Holter, Extended Holter |
| Medtronic, INC. | $274.28 | 2021-2025 | Cobalt Dr Mri Surescan, Launcher, Micra |
| Janssen Pharmaceuticals, INC | $256.85 | 2020-2023 | Xarelto |
| Amgen INC. | $180.73 | 2021-2025 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $171.26 | 2019-2025 | Camzyos, Eliquis |
| Atricure, INC. | $141.39 | 2019 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morhaf Ibrahim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.